doctor earns the patient? Parallel anesthetics put patients lives
Hamburg - The German Society for Anesthesiology and Intensive Care Medicine (DGAI) rejects - even temporarily - to care of patients whilst anesthesia Medical Assistant of Anesthesiology (MAFA) striktab. With over eight million anesthetics in the year could cost pressures not imGesundheitswesen with the restriction of medical services go hand in hand, said Professor van Aken, president of the DGAI and Director derKlinik Department of Anesthesiology and Intensive Care amUniversitätsklinikum Munster ahead of the Germans Anästhesiecongressesin Hamburg.Schwere anesthesia incidents are rare, but when they occur, then there are often life-threatening and dangerous crises. Insolchen situations is essential specialized medical expertise, threatening to harm the patient averted. Often lies between recognition of notifying the incident and its mastery of only a few minutes sodie experts DGAI. If the anesthesiologist, as in "MAFA" concept provided within shouting distance, for example, in another operating room, lack these vital minutes. "In addition, the first warning signs of complications are often not recognized and the Anästhesistoft is not called. We must never forget that routine interventions are never entirely risk-free. If the doctor in an incident even leave in the meantime the OP, it is außerdemein from serious medical error "says van Aken. "Anaesthetic management erforderteine continuous review of diagnosis and Therapy. Medical risks must also be considered in an assessment. Dasfällt clearly within the core area of medical activity, "ThePresident the DGAI.Die Appeals explained to a" Swiss model ", or experience of other countries woParallelnarkosen grown historically, van Aken is of the utmost concern," Whether anesthesia in these countries, dangerous or even safe inventor as in Germany has not been studied, "says van Aken in a Artikelder AINS journal" Anesthesiology Critical Care Emergency medical pain therapy ". Also a time to be drawn comparison with the USAhinke. There at many hospitals of CRNA anesthesia specialist nurses, alsoCertified Registered Nurses Anesthesia, performed with good results, as reported van Aken. But that possessed different from the medical assistant of anesthesiology of a multi-year university education and they were better trained in the hospitals as predicted based Mafas. Professor van Aken compares mitFlugzeugabstürzen fatal anesthetic incidents. In aviation, no one would dream of, the Pilot replaced by less qualified staff. This should also be imOperationssaal where the anesthesiologist is with the surgeon the most important key person for the safety and lives of patients. SCHEDULE NOTE: Delegation of medical services - how Doctors deserve a lot of patient DAC;? 5th May 2007, 12:30 to 14:30 Uh, Room 4, CCH Hamburg Source: Th Prien, E. Biermann, H. van Aken, parallel procedures in anesthesiology: Jaoder No, AINS - Anesthesiology Critical Care Emergency Medicine Pain Management 1-2007, Georg Thieme Verlag, Stuttgart (PDF)
Friday, February 23, 2007
Wednesday, February 7, 2007
Goldwell Elumen Salons Pittsburgh
German Society for Surgery again criticized Tissue Act of the Federal Government and offers solutions
? Berlin - The current federally-specified tissues law "will be difficult
tissue transplants significantly. During a hearing before
the Health Committee of the German Parliament in March, the DGCH
thus warns again of the consequences of the proposed "Law on Quality and
safety of human tissues and cells for medical
use. "In a recent opinion, the professional society
the surgeon should strongly consider their proposals for further legislation to
.
The draft law of the Federal Ministry of Health (BMG) to the
handling human cells and tissues in Germany in the future the
Drug Law (AMG) are subject. Before going around in a hospital taken
bone, blood vessels or heart valves on the way to the recipient,
need them like a drug to be approved. clinics, Keep removing the tissue
and will issue, is the proposed law so
pharmaceutical companies the same: it calls for mandatory registration and manufacturing license.
The BMG thus goes well above EU standards prescribed uniform
. Earlier on the part of DGCH amendments tabled
the ministry in a revised bill with little regard to
.
"The way to continue to pursue foreign control is excessively bureaucratic, and
generated additional costs for medical facilities, health insurance and
countries," says Professor Dr. Hartwig Bauer, general secretary of DGCH
in Berlin. Personnel and operating costs would be, for example, extremely high - among other things
by costly monitoring and reporting systems. "Most importantly, this approach involves
the risk of affecting patient care and reduce
by strict restrictions in the use of cells and tissues, the chances of the German
tissue medicine in the international research community to
," Professor Bauer.
The DGCH recommends, among other things, impute unworked tissues such as bone, blood vessels or heart valves
general the Transplantation Act (TPG) to
. Serve tissue-and cell harvesting the development of new therapies
had to handle this as well, possibly also separately regulate
. Only the further handling and processing of tissues or cells
to produce new drugs should come under the Medicines Act.
Because of the excessive requirements of the BMG, according DGCH
a meaningful implementation of the relevant EC directives had not yet occurred. In
an oral hearing before the Health Committee of the German Bundestag on 7
March 2007 in Berlin, the DGCH
with their member companies * represent their position. With her by Dr. Christoph
Gaissmaier of the BG Trauma Clinic Tübingen
prepared in advance and the BMG opinion received by the set
surgical societies a differentiated, legally and
practical approach before.
The complete statement of the German Society for Surgery
(DGCH) to bill the federal government about the quality and safety
of human tissues and cells (Tissue Act), interested
journalists www.dgch on request from the press office of the DGCH or online at
. de.
The German Society of Surgery and its member societies:
German Society for Vascular Surgery (DGG)
German Society for Pediatric Surgery (DGKCH)
German Society for Orthopaedics and Orthopaedic Surgery (DGOOC)
German Society of Plastic, Reconstructive and Aesthetic
Surgeons (DGPRÄC)
German Society for Thoracic Surgery (DGT)
German Society for Thoracic and Cardiovascular Surgery (DGTHG)
German Society for Accident Surgery (DGU)
German Society of Visceral Surgery (DGVC)
? Berlin - The current federally-specified tissues law "will be difficult
tissue transplants significantly. During a hearing before
the Health Committee of the German Parliament in March, the DGCH
thus warns again of the consequences of the proposed "Law on Quality and
safety of human tissues and cells for medical
use. "In a recent opinion, the professional society
the surgeon should strongly consider their proposals for further legislation to
.
The draft law of the Federal Ministry of Health (BMG) to the
handling human cells and tissues in Germany in the future the
Drug Law (AMG) are subject. Before going around in a hospital taken
bone, blood vessels or heart valves on the way to the recipient,
need them like a drug to be approved. clinics, Keep removing the tissue
and will issue, is the proposed law so
pharmaceutical companies the same: it calls for mandatory registration and manufacturing license.
The BMG thus goes well above EU standards prescribed uniform
. Earlier on the part of DGCH amendments tabled
the ministry in a revised bill with little regard to
.
"The way to continue to pursue foreign control is excessively bureaucratic, and
generated additional costs for medical facilities, health insurance and
countries," says Professor Dr. Hartwig Bauer, general secretary of DGCH
in Berlin. Personnel and operating costs would be, for example, extremely high - among other things
by costly monitoring and reporting systems. "Most importantly, this approach involves
the risk of affecting patient care and reduce
by strict restrictions in the use of cells and tissues, the chances of the German
tissue medicine in the international research community to
," Professor Bauer.
The DGCH recommends, among other things, impute unworked tissues such as bone, blood vessels or heart valves
general the Transplantation Act (TPG) to
. Serve tissue-and cell harvesting the development of new therapies
had to handle this as well, possibly also separately regulate
. Only the further handling and processing of tissues or cells
to produce new drugs should come under the Medicines Act.
Because of the excessive requirements of the BMG, according DGCH
a meaningful implementation of the relevant EC directives had not yet occurred. In
an oral hearing before the Health Committee of the German Bundestag on 7
March 2007 in Berlin, the DGCH
with their member companies * represent their position. With her by Dr. Christoph
Gaissmaier of the BG Trauma Clinic Tübingen
prepared in advance and the BMG opinion received by the set
surgical societies a differentiated, legally and
practical approach before.
The complete statement of the German Society for Surgery
(DGCH) to bill the federal government about the quality and safety
of human tissues and cells (Tissue Act), interested
journalists www.dgch on request from the press office of the DGCH or online at
. de.
The German Society of Surgery and its member societies:
German Society for Vascular Surgery (DGG)
German Society for Pediatric Surgery (DGKCH)
German Society for Orthopaedics and Orthopaedic Surgery (DGOOC)
German Society of Plastic, Reconstructive and Aesthetic
Surgeons (DGPRÄC)
German Society for Thoracic Surgery (DGT)
German Society for Thoracic and Cardiovascular Surgery (DGTHG)
German Society for Accident Surgery (DGU)
German Society of Visceral Surgery (DGVC)
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Free Games That You Can Give Birth
Solectron Herrenberg Receives Certification to ISO 13485:2003
The German factory in Solectron Herrenberg has received the medical certification to ISO 13485:2003. The certification is an important prerequisite for the production and delivery of medical equipment.
"This medical certification underscores our continued commitment to strict quality standards, "said Dr. Monika Reintjes, General Manager Solectron Germany." Receiving ISO 13485 certification increases our value in the eyes of our customers of the medical device area and increased our proven expertise across the supply chain. This fits perfectly with our growth strategy in the medical segment. "
Solectron Corporation is a leading provider of comprehensive services throughout the product life cycle. The company offers services in product design and new product introduction, supply chain management, lean manufacturing and services to the marketing, such as repairs under warranty and end-of-life support, at. Solectron works with global leaders in the areas of networking, telecommunications, computer, storage, consumer, automotive, industrial, medical, aerospace and defense.
The German factory in Solectron Herrenberg has received the medical certification to ISO 13485:2003. The certification is an important prerequisite for the production and delivery of medical equipment.
"This medical certification underscores our continued commitment to strict quality standards, "said Dr. Monika Reintjes, General Manager Solectron Germany." Receiving ISO 13485 certification increases our value in the eyes of our customers of the medical device area and increased our proven expertise across the supply chain. This fits perfectly with our growth strategy in the medical segment. "
Solectron Corporation is a leading provider of comprehensive services throughout the product life cycle. The company offers services in product design and new product introduction, supply chain management, lean manufacturing and services to the marketing, such as repairs under warranty and end-of-life support, at. Solectron works with global leaders in the areas of networking, telecommunications, computer, storage, consumer, automotive, industrial, medical, aerospace and defense.
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Body Temperature Circuit Diagram
new chief physician capacity in the Women's Health
Dr. Comlosan worked since February in the hospital Anhalt-Zerbst Zerbst
/ MZ. Dr. Zeno Comlosan since 1 February 2007 Head of the Department of Gynecology and Obstetrics at the General Hospital Medicare. Anhalt-Zerbst. He succeeds in this function, Dr. William Schmidt, who resigned for health reasons.
Comlosan was born in 1949 in the Romanian Banat. At the University of Timisoara He studied medicine and completed a gynecological specialist training.
He then worked as a specialist in the Women's Clinic of the hospital in Resita (Banat). 1986 Dr. Comlosan came after a brief stay in France in the Federal Republic of Germany. In order to work in Germany as a doctor, he confirmed later that year before the Medical Association of North Rhine-Westphalia in Dusseldorf his test as a specialist in gynecology and obstetrics. In the following years, distinguished himself Dr. Comlosan at various hospitals in Germany as a senior consultant and later as a senior consultant in the field of gynecology and obstetrics.
an important part of his medical Career provided a stay of several years in Scandinavia dar. at the University Hospital of Uppsala (Sweden) and Tromso (Norway), he focused particularly on the surgical treatment of gynecological diseases with emphasis on cancer surgery. In Scandinavia, Dr. Comlosan made familiar with various modern methods of treatment of female diseases. Had such as the University Hospital in Uppsala at the time a pioneering role in introducing a new surgical procedure for treatment of female urinary incontinence by tension-free tape to the deposit. Today, these so-called TVT operations, a standard procedure, which is also on Medi Cross Hospital Anhalt-Zerbst performed.
In his own words says Dr. Zeno Comlosan much on the new appointment on Zerbst hospital. Under his leadership the good performance to continue the clinic for gynecology and obstetrics in recent years. The clinic will continue to offer a wide range of services in the field of gynecology and obstetrics. Attaches particular importance to Dr. Comlosan established good contacts with the gynecologists in Zerbst and environment. In the efforts of recent years to strengthen cooperation tie he wants.
Dr. Comlosan is married and father of a child. Once it finds a suitable place, he will bring his family to Zerbst and hit roots here.
Dr. Comlosan worked since February in the hospital Anhalt-Zerbst Zerbst
/ MZ. Dr. Zeno Comlosan since 1 February 2007 Head of the Department of Gynecology and Obstetrics at the General Hospital Medicare. Anhalt-Zerbst. He succeeds in this function, Dr. William Schmidt, who resigned for health reasons.
Comlosan was born in 1949 in the Romanian Banat. At the University of Timisoara He studied medicine and completed a gynecological specialist training.
He then worked as a specialist in the Women's Clinic of the hospital in Resita (Banat). 1986 Dr. Comlosan came after a brief stay in France in the Federal Republic of Germany. In order to work in Germany as a doctor, he confirmed later that year before the Medical Association of North Rhine-Westphalia in Dusseldorf his test as a specialist in gynecology and obstetrics. In the following years, distinguished himself Dr. Comlosan at various hospitals in Germany as a senior consultant and later as a senior consultant in the field of gynecology and obstetrics.
an important part of his medical Career provided a stay of several years in Scandinavia dar. at the University Hospital of Uppsala (Sweden) and Tromso (Norway), he focused particularly on the surgical treatment of gynecological diseases with emphasis on cancer surgery. In Scandinavia, Dr. Comlosan made familiar with various modern methods of treatment of female diseases. Had such as the University Hospital in Uppsala at the time a pioneering role in introducing a new surgical procedure for treatment of female urinary incontinence by tension-free tape to the deposit. Today, these so-called TVT operations, a standard procedure, which is also on Medi Cross Hospital Anhalt-Zerbst performed.
In his own words says Dr. Zeno Comlosan much on the new appointment on Zerbst hospital. Under his leadership the good performance to continue the clinic for gynecology and obstetrics in recent years. The clinic will continue to offer a wide range of services in the field of gynecology and obstetrics. Attaches particular importance to Dr. Comlosan established good contacts with the gynecologists in Zerbst and environment. In the efforts of recent years to strengthen cooperation tie he wants.
Dr. Comlosan is married and father of a child. Once it finds a suitable place, he will bring his family to Zerbst and hit roots here.
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Venison Neck Roast Recie
genetic test detects deadly heart disease young people - implant could save lives
Berlin / Wiesbaden - a genetic defect on chromosome 12 is often a cause of
rare heart disease that is responsible for sudden deaths, especially in younger people
. The risk of "arrhythmogenic right ventricular cardiomyopathy
(ARVD) would be through a genetic test
early on - an electronic device could save the lives of those affected
. At a press conference of the German Society of Internal Medicine
(DGIM) in Berlin, Professor Dr. med
Ludwig Thierfelder, who discovered the genetic defect, in the project.
found in international studies, the heart specialist at the Max Delbrück Center for Molecular Medicine in Berlin
revealed that about a quarter of all patients with ARVD
a defect in the gene for the protein plakophilin-2.
It is part of the so-called intercalated discs, which interlock in the heart muscle
closely. The result of the genetic defect, loosen
connections between the cells. In the long run turns
tissue of the heart muscle in the connective and fatty tissue. From a young age
may occur in those affected with life-threatening heart rhythm disturbances
. Often they remain unnoticed for a long, but may at any time
sudden cardiac death . Trigger People with ARVD have a low life expectancy
- for some genetic defects it is below 40 years.
of the research group of Professor Thierfelder
developed genetic test can avert this fate. "If we identify these people have made
, is to help them effectively with an implantable cardioverter"
says the doctor. The defibrillator (ICD) or "definition" is not much bigger than
a heart pacemaker. Herznah planted it automatically detects the
fatal irregular heartbeat. The device then immediately from a current surge, which enables the heart
restart in normal rhythm.
"Our show together with another German, American and Canadian researchers
experience that the implantation of an ICD in
these people is very useful," explains Professor Thierfelder. The cardiologist started
therefore also in Germany to search for these patients
. Notes can frequent palpitations, an already
suffered cardiac arrest or similar cases are in the family. The patients usually have abnormal findings in
echocardiogram or electrocardiogram, which
by any doctor to easily manufactured electrocardiogram. Genetic tests can
in the diagnosis of ARVD are the crucial link. Slightly more than half
ARVD-gene carriers of the disease. "If the genetic defect identified in good time,
could save these people the implantation of a defibrillator life," says Professor
Thierfelder. On the 113th Annual Meeting of the DGIM in Wiesbaden
he referenced in this context, one of the main themes of the Congress
: molecular medicine.
DATE NOTE:
113th Annual Meeting of the German Society of Internal Medicine
Date: 14 to 18 April 2007
Location: Rhein-Main-Hallen, Wiesbaden
Berlin / Wiesbaden - a genetic defect on chromosome 12 is often a cause of
rare heart disease that is responsible for sudden deaths, especially in younger people
. The risk of "arrhythmogenic right ventricular cardiomyopathy
(ARVD) would be through a genetic test
early on - an electronic device could save the lives of those affected
. At a press conference of the German Society of Internal Medicine
(DGIM) in Berlin, Professor Dr. med
Ludwig Thierfelder, who discovered the genetic defect, in the project.
found in international studies, the heart specialist at the Max Delbrück Center for Molecular Medicine in Berlin
revealed that about a quarter of all patients with ARVD
a defect in the gene for the protein plakophilin-2.
It is part of the so-called intercalated discs, which interlock in the heart muscle
closely. The result of the genetic defect, loosen
connections between the cells. In the long run turns
tissue of the heart muscle in the connective and fatty tissue. From a young age
may occur in those affected with life-threatening heart rhythm disturbances
. Often they remain unnoticed for a long, but may at any time
sudden cardiac death . Trigger People with ARVD have a low life expectancy
- for some genetic defects it is below 40 years.
of the research group of Professor Thierfelder
developed genetic test can avert this fate. "If we identify these people have made
, is to help them effectively with an implantable cardioverter"
says the doctor. The defibrillator (ICD) or "definition" is not much bigger than
a heart pacemaker. Herznah planted it automatically detects the
fatal irregular heartbeat. The device then immediately from a current surge, which enables the heart
restart in normal rhythm.
"Our show together with another German, American and Canadian researchers
experience that the implantation of an ICD in
these people is very useful," explains Professor Thierfelder. The cardiologist started
therefore also in Germany to search for these patients
. Notes can frequent palpitations, an already
suffered cardiac arrest or similar cases are in the family. The patients usually have abnormal findings in
echocardiogram or electrocardiogram, which
by any doctor to easily manufactured electrocardiogram. Genetic tests can
in the diagnosis of ARVD are the crucial link. Slightly more than half
ARVD-gene carriers of the disease. "If the genetic defect identified in good time,
could save these people the implantation of a defibrillator life," says Professor
Thierfelder. On the 113th Annual Meeting of the DGIM in Wiesbaden
he referenced in this context, one of the main themes of the Congress
: molecular medicine.
DATE NOTE:
113th Annual Meeting of the German Society of Internal Medicine
Date: 14 to 18 April 2007
Location: Rhein-Main-Hallen, Wiesbaden
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Thursday, February 1, 2007
Celebrities Who Live In Cheongdam?
strengthening of clinical research in Germany
German Society of Internal Medicine
urges strengthening of clinical research in Germany
Berlin - The German Society of Internal Medicine (DGIM) provides for the
university clinical research in Germany in a dilemma:
science perspective is considered crucial for the future. The
variety of meaningful, high-quality programs is great. Nevertheless, says DGIM
is the clinical research often doomed to failure
, as the researchers themselves are increasingly burdened and
are paid less. DGIM experts discussed this today in
a press conference in Berlin.
Clinical Research comprises mainly of university research
at and for the patient. On the one hand, one clinic near
basic research. This examines processes which lead to the creation of
diseases. On the other hand, are clinical trials to develop
prevention, early detection, diagnosis and treatment of diseases to
and tested. "In fact, many of the currently
initiated programs in principle suitable to reach these high goals
," said Professor Wolfgang Hiddemann, MD, Chairman of the
DGIM. Excellence initiatives, or competence networks pursued as
the right approach: you assign resources
clinical research according to certain quality criteria to designated
working groups. Laws and regulations, but considerably more difficult
the implementation, says the director of the Medical Clinic and Policlinic III
at the Hospital of the Ludwig-Maximilian University in Munich
.
According DGIM hampered above all the new Higher Education Act
clinical research at universities in Germany - the last
amended on 1 January 2007. The Regulation has determined under
alia the framework for new managers: The
W-grade replaces the C-grade. If a habilitation
clinically experienced senior physician a W2 professorship at reduced with
base salary was around 600, - €. Also covered compensation for overtime and standby service
away without compensation. "So what should this
colleagues motivated to pursue a scientific career
and a professor to compete?" Says the president of the Congress this year's 113th
to consider annual meeting of the DGIM. Already a
significant decrease of the next generation of medical
university hospitals was noted. Only a relatively small proportion of candidates
interest in medical research and
have a university career. This
illustrate a central dilemma: "All no matter how reasonable
programs to strengthen clinical research at the universities
will fail because do that, those who make this research
and do demotivated substantial and disillusioned
be, "said Professor Hiddemann. To the undoubted great
potential use of university clinical research in Germany,
needed young, rising scientists
the appropriate support from federal and state policy.
German Society of Internal Medicine
urges strengthening of clinical research in Germany
Berlin - The German Society of Internal Medicine (DGIM) provides for the
university clinical research in Germany in a dilemma:
science perspective is considered crucial for the future. The
variety of meaningful, high-quality programs is great. Nevertheless, says DGIM
is the clinical research often doomed to failure
, as the researchers themselves are increasingly burdened and
are paid less. DGIM experts discussed this today in
a press conference in Berlin.
Clinical Research comprises mainly of university research
at and for the patient. On the one hand, one clinic near
basic research. This examines processes which lead to the creation of
diseases. On the other hand, are clinical trials to develop
prevention, early detection, diagnosis and treatment of diseases to
and tested. "In fact, many of the currently
initiated programs in principle suitable to reach these high goals
," said Professor Wolfgang Hiddemann, MD, Chairman of the
DGIM. Excellence initiatives, or competence networks pursued as
the right approach: you assign resources
clinical research according to certain quality criteria to designated
working groups. Laws and regulations, but considerably more difficult
the implementation, says the director of the Medical Clinic and Policlinic III
at the Hospital of the Ludwig-Maximilian University in Munich
.
According DGIM hampered above all the new Higher Education Act
clinical research at universities in Germany - the last
amended on 1 January 2007. The Regulation has determined under
alia the framework for new managers: The
W-grade replaces the C-grade. If a habilitation
clinically experienced senior physician a W2 professorship at reduced with
base salary was around 600, - €. Also covered compensation for overtime and standby service
away without compensation. "So what should this
colleagues motivated to pursue a scientific career
and a professor to compete?" Says the president of the Congress this year's 113th
to consider annual meeting of the DGIM. Already a
significant decrease of the next generation of medical
university hospitals was noted. Only a relatively small proportion of candidates
interest in medical research and
have a university career. This
illustrate a central dilemma: "All no matter how reasonable
programs to strengthen clinical research at the universities
will fail because do that, those who make this research
and do demotivated substantial and disillusioned
be, "said Professor Hiddemann. To the undoubted great
potential use of university clinical research in Germany,
needed young, rising scientists
the appropriate support from federal and state policy.
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Subscribe to:
Posts (Atom)